Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities

Journal of the American Geriatrics Society

Volumn 49, Issue 7, 2001, Pages 985-990

  Bartrés Faz, David ^a,b   Junqué, Carme ^a   López Alomar, Antoni ^b   Valveny, Neus ^b   Moral, Pedro ^b   Casamayor, Robert ^c   Salido, Antoni ^c   Bel, Carme ^d   Clemente, Imma C ^a  

^a Facultat de Psicologia   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CAP Castellar del Valles   (Spain)

^d CAP Merinals (Sabadell)   (Spain)

Author keywords

AAMI; Apolipoprotein E; Genetics; MCI; Neuropsychological

Indexed keywords

APOLIPOPROTEIN E; RESTRICTION ENDONUCLEASE;

ADULT; AGE; AGED; AMNESIA; ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FRONTAL LOBE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HEREDITY; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MEMORY; NEUROPSYCHOLOGY; POLYMERASE CHAIN REACTION; PSYCHOLOGIC TEST; RISK FACTOR;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; GENE FREQUENCY; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 0034890637     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2001.49191.x     Document Type: Article

References (43)

1. Senescent forgetfulness: Benign and malignant
2. Senescent forgetfulness: A quantitative study
3. Age-associated memory impairment: Diagnostic criteria and treatment strategies
4. Mild cognitive impairment: Conceptual basis and current nosological status
5. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change
6. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: Correlation to visual and verbal memory
7. 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease
8. Age-associated memory impairment and early Alzheimer's disease. Only time will rell the difference
9. Apo E influences declarative and procedural learning in age-associated memory impairment
10. AAMI
11. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland
12. Age associated memory impairment. Too broad an enrity to justify drug treatment yet
13. Age-associated memory impairment diagnoses: Problems of reliability and concerns for terminology
14. Criteria for diagnosing age associated memory impairment: Proposed improvements from the field
15. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
16. Predictive value of ApoE genotyping in incipient Alzheimer's disease
17. Clinical Dementia Rating (CDR)
18. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
19. A follow-up study of ageassociated memory impairment: Neuropsychological predictors of dementia
20. Age-associated memory impairmentpathological memory decline or normal aging?
21. Stability of age-associated memory impairment during a longitudinal population-based study
22. Mild cognitive impairment: Clinical characterization and outcome
23. Mild cognitive impairment in the elderly: Predictors of dementia
24. Very mild senile dementia of the Alzheimer type. I: Clinical assessment
25. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects
26. Definition, course, and outcome of mild cognitive impairment
27. Cognitive decline in ageing: Are AAMI and AACD distinct entities?
28. A double-blind, control study of huperzine A and piracetam in patients with age-associated memory impairment and Alzheimer's disease
29. Mild cognitive impairment raises Alzheimer disease risk
30. APO E polymorphism in Spanish and Moroccan populations
31. Apolipoprotein E: Risk factor for Alzheimer disease
32. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
33. Decline of frontal lobe functions in subjects with age-associated memory impairment
34. Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients
35. Apolipoprotein E: High-avidity binding to β amyloid and increased frequency of type e4 allele in late-onset familial Alzheimer's disease
36. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease
37. Protection against Alzheimer's disease with apoE ε2
38. Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease
39. Apo E allele frequencies in Italian spotadic and familial Alzheimer's disease
40. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival
41. Apolipoprotein E polymorphism and silent micro angiopathy-related cerebral damage. Results of the Austrian stroke prevention study
42. Leuko-ataiosis on magnetic resonance imaging and speed of mental processing